Genomic Insights into Virulence Factors and Multi-Drug Resistance in Clostridium perfringens IRMC2505A

Toxins (Basel). 2023 May 25;15(6):359. doi: 10.3390/toxins15060359.

Abstract

Clostridium perfringens is a spore-forming, Gram-positive anaerobic pathogen that causes several disorders in humans and animals. A multidrug-resistant Clostridium strain was isolated from the fecal sample of a patient who was clinically suspected of gastrointestinal infection and had a recent history of antibiotic exposure and diarrhea. The strain was identified by 16s rRNA sequencing as Clostridium perfringens. The strain's pathogenesis was analyzed through its complete genome, specifically antimicrobial resistance-related genes. The Clostridium perfringens IRMC2505A genome contains 19 (Alr, Ddl, dxr, EF-G, EF-Tu, folA, Dfr, folP, gyrA, gyrB, Iso-tRNA, kasA, MurA, rho, rpoB, rpoC, S10p, and S12p) antibiotic-susceptible genetic species according to the k-mer-based detection of antimicrobial resistance genes. Genome mapping using CARD and VFDB databases revealed significant (p-value = 1 × 10-26) genes with aligned reads against antibiotic-resistant genes or virulence factors, including phospholipase C, perfringolysin O, collagenase, hyaluronidase, alpha-clostripain, exo-alpha-sialidase, and sialidase activity. In conclusion, this is the first report on C. perfringens from Saudi Arabia that conducted whole genome sequencing of IRMC2505A and confirmed the strain as an MDR bacterium with several virulence factors. Developing control strategies requires a detailed understanding of the epidemiology of C. perfringens, its virulence factors, and regional antimicrobial resistance patterns.

Keywords: Clostridium; anaerobic pathogen; genome mapping; multi-drug resistant; resistance genes; virulence.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Clostridium Infections* / microbiology
  • Clostridium perfringens*
  • Drug Resistance, Multiple
  • Genomics
  • Humans
  • RNA, Ribosomal, 16S
  • Virulence Factors / genetics

Substances

  • Virulence Factors
  • RNA, Ribosomal, 16S
  • Anti-Bacterial Agents

Grants and funding

This research received no external funding.